Honey and Nigella Sativa in COVID-19 Prophylaxis

Overview

Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis

Full Title of Study: “Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: February 15, 2022

Interventions

  • Drug: Honey
    • 0.5 gm/Kg/day honey
  • Drug: Nigella sativa seed
    • 40 mg/Kg/day
  • Other: Placebo
    • empty capsule with sugar water

Arms, Groups and Cohorts

  • Active Comparator: Honey and Nigella sativa Arm
    • 0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds
  • Placebo Comparator: Placebo Arm
    • empty capsule with sugar water

Clinical Trial Outcome Measures

Primary Measures

  • SARS-CoV-2 infection rate
    • Time Frame: 14 days
    • RT-PCR SARS-CoV-2

Participating in This Clinical Trial

Inclusion Criteria

  • Health care professionals Post-exposure COVID-19 Exclusion Criteria:

  • Multi-organ failure active COVID-19

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Sohaib Ashraf
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Sohaib Ashraf, Registrar Cardiology – Sheikh Zayed Federal Postgraduate Medical Institute
  • Overall Official(s)
    • Sohaib Ashraf, MBBS, Study Director, Massachusetts General Hospital
    • Muhammad Ashraf, PhD, Study Chair, University of Veterinary and Animal Sciences
    • Ahmad Imran, MBBS, Principal Investigator, Shaikh Zayed Post-Graduate Medical Institute
    • Moneeb Ashraf, MBBS, Principal Investigator, King Edward Medical University
  • Overall Contact(s)
    • Sohaib Ashraf, MBBS, 8573167995, sohaib@skzmdc.edu.pk

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.